Pfizer Terminates Biometrics Services Contract With India’s Siro Clinpharm
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pfizer has terminated its clinical data management and biometrics services contract with India's Siro Clinpharm as part of its "global strategy to reduce the number of biometric suppliers." Siro Clinpharm is one of the largest and most established players in the Indian clinical research industry
You may also be interested in...
India's Largest CRO Siro Clinpharm Is Up For Grabs; Will Biocon Bag It Or Is A Bidding War On?
MUMBAI - The extensively polarized Indian clinical research industry is finally set for a top-level consolidation as India's biotechnology company Biocon is reported to have made a bid to buy out Siro Clinpharm - one of the earliest entrants and an established player in the clinical and data management business
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).